These findings led us to hypothesize that if glycolytic flux increases due to HIV-1 infection, glycolytic enzymes such as ENO1 must be involved in glycolysis, and HIV-1 replication will not be inhibited by ENO1. The gene discussed is ENO1; the disease is HIV-1 infection.